James Crowe

December 19, 2013

Year in review 2013: A year of achievements, transition for VUMC

By Doug Campbell
September 5, 2013

Controversial info release aids VUMC bird flu research

Vanderbilt research shows that human antibodies to the natural strain of H5N1 also protected against a dangerous lab-created airborne strain developed several years ago by scientists in the Netherlands and at the University of Wisconsin.

By VUMC News and Communications
August 22, 2013

Vaccine researchers ready as new flu strain evolves

A worrisome new avian influenza virus, called H7N9, emerged this spring in Eastern China.

By VUMC News and Communications
July 18, 2013

VU researchers ‘goldsmith’ new RSV vaccine approach

Vanderbilt vaccine researchers are using gold nanotechnology to develop a new approach to making vaccines.

By VUMC News and Communications
May 30, 2013

Study lays groundwork for rational T cell vaccine design

Vanderbilt University investigators have developed a new strategy for identifying the “bits” of a pathogen that spark a protective immune response.

By Leigh MacMillan
May 16, 2013

Grant targets new therapies for Ebola, Marburg viruses

Vanderbilt’s James Crowe Jr., M.D., and a collaborator in Texas have been awarded a $4.4 million grant from the U.S. Department of Defense to study new ways to treat and prevent Ebola and Marburg viruses.

By VUMC News and Communications
April 4, 2013

Symposium to offer look at latest infectious diseases imaging research

The latest research on imaging infectious diseases will be discussed during a mini-symposium noon to 5 p.m., April 12, at the Vanderbilt Student Life Center Board of Trust Room.
By Bill Snyder
February 21, 2013

Structural snapshot hints at new influenza approach

A careful look at how the body’s natural defenses disarm virulent strains of influenza hints at the possibility of a way to fight the flu.
By VUMC News and Communications
December 6, 2012

Repository samples help shape view of new rhinovirus

Vanderbilt researchers used a treasure trove of samples collected and stored at the Vanderbilt Vaccine Clinic (VVC) to prove a particular human rhinovirus (HRV), has been causing more than just the common cold for decades.
By VUMC News and Communications
November 1, 2012

Genomic research gains ad-“vantage” with new resources

Vanderbilt University Medical Center has stepped up its support of research aimed at cracking the mysteries of the genome, the master DNA code.
By Bill Snyder
July 19, 2012

Long antibodies better against HIV

Understanding how antibodies with long “loops” form may be important for HIV vaccine development.
By Leigh MacMillan
April 27, 2012

Dengue antibodies give vaccine leads

New information may help speed development of a vaccine or treatment for dengue fever.
By VUMC News and Communications
April 12, 2012

Targeting post-transplant diabetes

Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes.
By VUMC News and Communications
1 … 10 11 12 13 14